Lv1
90 积分 2025-09-02 加入
Unlocking the full clinical potential of the α-synuclein seed amplification assay
1天前
已完结
PET tracer development for imaging α-synucleinopathies
2天前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
10个月前
已完结